115 related articles for article (PubMed ID: 31471573)
21. Hematopoietic cell transplantation for B-cell lymphoma: an update.
Ayala E
Cancer Control; 2012 Jul; 19(3):175-86. PubMed ID: 22710893
[TBL] [Abstract][Full Text] [Related]
22. Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Brudno JN; Lam N; Vanasse D; Shen YW; Rose JJ; Rossi J; Xue A; Bot A; Scholler N; Mikkilineni L; Roschewski M; Dean R; Cachau R; Youkharibache P; Patel R; Hansen B; Stroncek DF; Rosenberg SA; Gress RE; Kochenderfer JN
Nat Med; 2020 May; 26(5):803. PubMed ID: 32291416
[TBL] [Abstract][Full Text] [Related]
23. Author Correction: Velocity and density characteristics of subducted oceanic crust and the origin of lower-mantle heterogeneities.
Wang W; Xu Y; Sun D; Ni S; Wentzcovitch R; Wu Z
Nat Commun; 2020 May; 11(1):2247. PubMed ID: 32366849
[TBL] [Abstract][Full Text] [Related]
24. Author Correction: 3D shear wave velocity model of the crust and uppermost mantle beneath the Tyrrhenian basin and margins.
Manu-Marfo D; Aoudia A; Pachhai S; Kherchouche R
Sci Rep; 2019 Aug; 9(1):12100. PubMed ID: 31417108
[TBL] [Abstract][Full Text] [Related]
25. Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome.
Santiago V; Lazaryan A; McClune B; McKenna RW; Courville EL
Leuk Lymphoma; 2018 Apr; 59(4):958-966. PubMed ID: 28728454
[TBL] [Abstract][Full Text] [Related]
26. Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma.
Till BG
Curr Treat Options Oncol; 2018 Jul; 19(9):45. PubMed ID: 30032463
[TBL] [Abstract][Full Text] [Related]
27. High-dose treatment with autologous haemopoietic progenitor cell support for large B-cell, follicular and mantle-cell lymphoma.
Rohatiner AZ
Best Pract Res Clin Haematol; 2002 Sep; 15(3):467-80. PubMed ID: 12468400
[TBL] [Abstract][Full Text] [Related]
28. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
[TBL] [Abstract][Full Text] [Related]
29. Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Calderón-Cabrera C; Márquez-Malaver FJ; de la Cruz-Vicente F; Falantes F; Carrillo E; Parody R; Montero I; González Campos J; Martino ML; Carmona M; Pérez-Simón JA; Espigado I
Transplant Proc; 2013; 45(10):3665-7. PubMed ID: 24314990
[TBL] [Abstract][Full Text] [Related]
30. Publisher Correction: Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins.
Torrens G; Barceló IM; Pérez-Gallego M; Escobar-Salom M; Tur-Gracia S; Munar-Bestard M; González-Nicolau MDM; Cabrera-Venegas YJ; Rigo-Rumbos EN; Cabot G; López-Causapé C; Rojo-Molinero E; Oliver A; Juan C
Sci Rep; 2020 Mar; 10(1):4356. PubMed ID: 32132557
[TBL] [Abstract][Full Text] [Related]
31. CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma.
Berger MD; Branger G; Leibundgut K; Baerlocher GM; Seipel K; Mueller BU; Gregor M; Ruefer A; Pabst T
Leuk Res; 2015 Jun; 39(6):561-7. PubMed ID: 25890431
[TBL] [Abstract][Full Text] [Related]
32. Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell lymphoma.
Bolwell B; Kalaycio M; Andresen S; Goormastic M; McBee M; Kuczkowski E; Wise K; Sobecks R; Pohlman B
Clin Lymphoma; 2000 Dec; 1(3):226-31; discussion 232-3. PubMed ID: 11707835
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
[TBL] [Abstract][Full Text] [Related]
34. Publisher Correction: Follicular lymphoma.
Nat Rev Dis Primers; 2020 Sep; 6(1):75. PubMed ID: 32929095
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning.
Rezvani AR; Kanate AS; Efron B; Chhabra S; Kohrt HE; Shizuru JA; Laport GG; Miklos DB; Benjamin JE; Johnston LJ; Arai S; Weng WK; Negrin RS; Strober S; Lowsky R
Bone Marrow Transplant; 2015 Oct; 50(10):1286-92. PubMed ID: 26146806
[TBL] [Abstract][Full Text] [Related]
37. Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells.
Pavel-Dinu M; Wiebking V; Dejene BT; Srifa W; Mantri S; Nicolas CE; Lee C; Bao G; Kildebeck EJ; Punjya N; Sindhu C; Inlay MA; Saxena N; DeRavin SS; Malech H; Roncarolo MG; Weinberg KI; Porteus MH
Nat Commun; 2019 Dec; 10(1):5624. PubMed ID: 31796738
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
[TBL] [Abstract][Full Text] [Related]
39. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?
Atilla E; Atilla PA; Demirer T
Int J Hematol; 2017 Mar; 105(3):257-264. PubMed ID: 27995456
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
